This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://bio2rdf.org/drugbank:
n13http://linked.opendata.cz/resource/drugbank/drug/DB04266/identifier/pdb/
admshttp://www.w3.org/ns/adms#
n6http://linked.opendata.cz/resource/drugbank/drug/DB04266/identifier/pubchem-compound/
n9http://linked.opendata.cz/resource/drugbank/drug/DB04266/identifier/pubchem-substance/
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n12http://linked.opendata.cz/resource/drugbank/drug/DB04266/identifier/drugbank/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04266
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n8:DB04266 n11:DB04266
dcterms:title
5-(6-D-Ribitylamino-2,4-Dihydroxypyrimidin-5-Yl)-1-Pentyl-Phosphonic Acid
adms:identifier
n6:46936937 n9:46506658 n12:DB04266 n13:INJ
n3:IUPAC-Name
n4:271B4A05-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4A0B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4A0A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4A07-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4A08-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4A09-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4A03-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4A04-363D-11E5-9242-09173F13E4C5 n4:271B4A01-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4A02-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4A11-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4A12-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4A0C-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4A0D-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4A0F-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4A0E-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4A10-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4A17-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4A19-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4A1A-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4A16-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4A15-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4A18-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4A06-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4A13-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4A14-363D-11E5-9242-09173F13E4C5